Tourmaline Bio
Developing transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Learn more
Launch date
Employees
Market cap
$494m
Enterprise valuation
$205m (Public information from Sep 2024)
Share price
$22.6 TRML
New York City New York (HQ)
Authorizing premium user...